The development of imatinib as a therapeutic agent for chronic myeloid leukemia (Q35993288): Difference between revisions
Jump to navigation
Jump to search
Changed Asturian label: The development of imatinib as a therapeutic agent for chronic myeloid leukemia |
Added reference to claim: cites work (P2860): RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class (Q34308033), batch #220245 |
||||||||||||||
| (6 intermediate revisions by 3 users not shown) | |||||||||||||||
| label / en | label / en | ||||||||||||||
The development of imatinib as a therapeutic agent for chronic myeloid leukemia | The development of imatinib as a therapeutic agent for chronic myeloid leukemia | ||||||||||||||
| label / nl | label / nl | ||||||||||||||
The development of imatinib as a therapeutic agent for chronic myeloid leukemia | The development of imatinib as a therapeutic agent for chronic myeloid leukemia | ||||||||||||||
| Property / title | Property / title | ||||||||||||||
The development of imatinib as a therapeutic agent for chronic myeloid leukemia (English) | |||||||||||||||
| Property / author | Property / author | ||||||||||||||
| Property / Fatcat ID | |||||||||||||||
| Property / Fatcat ID: release_u7mrqcbq7fcnpo4jc4elt4rf7i / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Fatcat ID: release_u7mrqcbq7fcnpo4jc4elt4rf7i / reference | |||||||||||||||
stated in: Fatcat reference URL: https://api.fatcat.wiki/v0/release/u7mrqcbq7fcnpo4jc4elt4rf7i retrieved: 24 November 2022
based on heuristic: mapped directly with Wikidata item | |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class / reference | |||||||||||||||
stated in: COCI retrieved: 30 December 2023
reference URL: https://opencitations.net/index/api/v1/citations/10.1073/PNAS.92.7.2558 | |||||||||||||||
Latest revision as of 09:49, 30 December 2023
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The development of imatinib as a therapeutic agent for chronic myeloid leukemia |
scientific article |
Statements
1 reference
The development of imatinib as a therapeutic agent for chronic myeloid leukemia (English)
1 reference
Michael Deininger
1 reference
Elisabeth Buchdunger
1 reference
23 December 2004
1 reference
1 reference
105
1 reference
7
1 reference
2640-2653
1 reference
1 reference
Identifiers
1 reference
1 reference